GEUSENS, Piet

Email Alert RSS Feed

Profile

Full Name
GEUSENS, Piet
Email
piet.geusens@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Author:  Mease, Philip J.

Results 1-10 of 10 (Search time: 0.003 seconds).

Issue DateTitleContributor(s)TypeCat.
12019SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS IN PSORIATIC ARTHRITIS: FINAL 5 YEAR EFFICACY AND SAFETY RESULTS FROM A PHASE 3 TRIALMease, Philip J.; Kavanaugh, Arthur; Reimold, Andreas; Tahir, Hasan; Rech, Juergen; Hall, Stephen; GEUSENS, Piet; Pellet, Pascale; Delicha, Eumorphia Maria; Pricop, Luminita; Mpofu, ShephardJournal ContributionM
22019SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS IN PSORIATIC ARTHRITIS: FINAL 5-YEAR EFFICACY AND SAFETY RESULTS FROM THE FUTURE 1 PHASE 3 TRIALTahir, Hasan; Mease, Philip J.; Kavanaugh, Arthur; Reimold, Andreas; Rech, Juergen; Hall, Stephen; GEUSENS, Piet; Pellet, Pascale; Delicha, Eumorphia Maria; Pricop, Luminita; Mpofu, ShephardJournal ContributionM
32018Secukinumab Provides Sustained Improvements in the Signs and Symptoms in Psoriatic Arthritis: Final 5 Year Efficacy and Safety Results from a Phase 3 TrialMease, Philip J.; Kavanaugh, Arthur; Reimold, Andreas; Tahir, Hasan; Rech, Juergen; Hall, Stephen; GEUSENS, Piet; Pascale, Pellet; Delicha, Evie Maria; Pricop, Luminita; Mpofu, ShephardJournal ContributionM
42017Secukinumab provides sustained improvements in the signs and symptoms of active psoriatic arthritis: 3-year efficacy and safety results from phase 3 future 1 trialMease, Philip J.; Kavanaugh, Arthur; Reimold, Andreas; Tahir, Hasan; Rech, Juergen; Hall, Stephen; GEUSENS, Piet; Pascale, Pellet; Delicha, Evie Marie; Pricop, Luminata; Mpofu, ShepardJournal ContributionM
52009Proposal for Levels of Evidence Schema for Validation of a Soluble Biomarker Reflecting Damage Endpoints in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis, and Recommendations for Study DesignMaksymowych, Walter P.; Fitzgerald, Oliver; Wells, George A.; Gladman, Dafna D.; Landewe, Robert; Ostergaard, Mikkel; Taylor, William J.; Christensen, Robin; Tak, Paul-Peter; Boers, Maarten; Syversen, Silje W.; Bathon, Joan M.; Ritchlin, Christopher J.; Mease, Philip J.; Bykerk, Vivien P.; Garnero, Patrick; GEUSENS, Piet; El-Gabalawy, Hani; Aletaha, Daniel; Inman, Robert D.; Kraus, Virginia Byers; Kvien, Tore K.; VAN DER HEIJDE, DesireeJournal ContributionA1
62009Reappraisal of OMERACT 8 Draft Validation Criteria for a Soluble Biomarker Reflecting Structural Damage Endpoints in Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis: The OMERACT 9 v2 CriteriaMaksymowych, Walter P.; Landewe, Robert; Tak, Paul-Peter; Ritchlin, Christopher J.; Ostergaard, Mikkel; Mease, Philip J.; El-Gabalawy, Hani; Garnero, Patrick; Gladman, Dafna D.; Fitzgerald, Oliver; Aletaha, Daniel; Bykerk, Vivien P.; Bathon, Joan M.; Syversen, Silje W.; Boers, Maarten; GEUSENS, Piet; Inman, Robert D.; Kraus, Virginia B.; Kvien, Tore K.; Taylor, William J.; Wells, George A.; VAN DER HEIJDE, DesireeJournal ContributionA1
72009Testing of the OMERACT 8 Draft Validation Criteria for a Soluble Biomarker Reflecting Structural Damage in Rheumatoid Arthritis: A Systematic Literature Search on 5 Candidate BiomarkersSyversen, Silje W.; Landewe, Robert; VAN DER HEIJDE, Desiree; Bathon, Joan M.; Boers, Maarten; Bykerk, Vivian P.; Fitzgerald, Oliver; Gladman, Dafna D.; Garnero, Patrick; GEUSENS, Piet; El-Gabalawy, Hani; Inman, Robert D.; Kraus, Virginia; Kvien, Tore K.; Mease, Philip J.; Ostergaard, Mikkel; Ritchlin, Christopher J.; Tak, Paul-Peter; Taylor, William J.; Maksymowych, Walter P.Journal ContributionA1
82007Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trialKavanaugh, A.; Krueger, G. G.; Beutler, A.; Guzzo, C.; Zhou, B.; Dooley, L. T.; Mease, Philip J.; Gladman, D. D.; de Vlam, K.; GEUSENS, Piet; Birbara, C.; Halter, D. G.; Antoni, C.Journal ContributionA1
92006Sustained improvement in clinical measures of psoriatic arthritis in infliximab-treated patients: 1 year results from impact 2Kavanaugh, A.; Antoni, C.; Krueger, G. G.; Gladman, D. D.; Birbara, C.; Boling, E.; Siegel, E.; Halter, D.; GEUSENS, Piet; De Vlam, K.; Kirkham, B.; Beutler, A.; Guzzo, C.; Zhou, B.; Dooley, L. T.; Mease, Philip J.Journal ContributionM
102005Improvement in-clinical measures of psoriatic arthritis in infliximab-treated patients: 1 year results from IMPACT 2.Kavanaugh, A; Antoni, C.E.; Krueger, GG; Gladman, D; Birbara, C; Boling, EP; Siegel, EL; Halter, DG; de Vlam, K; Kirkham, B; Beutler, A; Guzzo, C; Zhou, B; Dooley, LT; Mease, Philip J.; GEUSENS, PietJournal ContributionM